EUVIMEDEUVIMED entdecken
Open Access

Extracellular Vesicles in Kidney Diseases: Moving Forward

Uta Erdbrügger, Ewout J Hoorn, Thu H Le, Charles J Blijdorp, Dylan Burger

Kidney360 · 2023-02 · 4 (2) · 245-257

DOI: 10.34067/kid.0001892022 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Kidney360, online erschienen am 18.12.2022. Verfasst von Uta Erdbrügger und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology, Department of Medicine, University of Virginia Health System, Charlottesville, Virginia. Hauptthemen laut MEDLINE: Kidney Diseases, Extracellular Vesicles. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 117 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Extracellular vesicles (EVs) are evolving as novel cell mediators, biomarkers, and therapeutic targets in kidney health and disease. They are naturally derived from cells both within and outside the kidney and carry cargo which mirrors the state of the parent cell. Thus, they are potentially more sensitive and disease-specific as biomarkers and messengers in various kidney diseases. Beside their role as novel communicators within the nephron, they likely communicate between different organs affected by various kidney diseases. Study of urinary EVs (uEVs) can help to fill current knowledge gaps in kidney diseases. However, separation and characterization are challenged by their heterogeneity in size, shape, and cargo. Fortunately, more sensitive and direct EV measuring tools are in development. Many clinical syndromes in nephrology from acute to chronic kidney and glomerular to tubular diseases have been studied. Yet, validation of biomarkers in larger cohorts is warranted and simpler tools are needed. Translation from in vitro to in vivo studies is also urgently needed. The therapeutic role of uEVs in kidney diseases has been studied extensively in rodent models of AKI. On the basis of the current exponential growth of EV research, the field of EV diagnostics and therapeutics is moving forward.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Kidney DiseasesExtracellular VesiclesHumansKidneyKidney GlomerulusBiomarkers

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Division of Nephrology, Department of Medicine, University of Virginia Health System, Charlottesville, Virginia.
  • Division of Nephrology and Transplantation, Department of Internal Medicine, Erasmus Medical Center, University Medical Center Rotterdam, Rotterdam, The Netherlands.
  • Division of Nephrology, Department of Medicine, University of Rochester Medical Center, Rochester, New York.
  • Kidney Research Centre, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
  • Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, Ontario, Canada.

Zitieren

APA

Erdbrügger, U., Hoorn, E. J., Le, T. H., Blijdorp, C. J., & Burger, D. (2023). Extracellular Vesicles in Kidney Diseases: Moving Forward. Kidney360, 4(2), 245-257. https://doi.org/10.34067/kid.0001892022

Vancouver

Erdbrügger U, Hoorn EJ, Le TH, Blijdorp CJ, Burger D. Extracellular Vesicles in Kidney Diseases: Moving Forward. Kidney360. 2023;4(2):245-257. doi:10.34067/kid.0001892022

BibTeX
@article{Erdbrgger2023,
  author = {Erdbrügger, Uta and Hoorn, Ewout J and Le, Thu H and Blijdorp, Charles J and Burger, Dylan},
  title = {Extracellular Vesicles in Kidney Diseases: Moving Forward},
  journal = {Kidney360},
  year = {2023},
  volume = {4},
  number = {2},
  pages = {245--257},
  doi = {10.34067/kid.0001892022}
}
Kostenlos starten →